Stomach Cancer – China Cancer Help

CLAUDIN 18.2 CELLULAR THERAPY & GASTRIC CARE

Advanced Stomach Cancer Care in China

Stomach (gastric) cancer is widely treated in East Asia, giving Chinese surgeons and oncologists unmatched clinical mastery. China holds world-first approvals for Claudin 18.2 targeted cellular therapies and dual-target immunotherapies, offering groundbreaking solutions for advanced and metastatic gastric cancer alongside organ-preserving surgical techniques.

ADVANCED TREATMENT OPTIONS

Key Stomach Cancer Treatments

Breakthrough Claudin 18.2 living cell therapy, robotic gastrectomy, and heated intraperitoneal chemotherapy (HIPEC).

Claudin 18.2 CAR-T Cell Therapy

China's groundbreaking living cell therapy and targeted antibodies specifically designed to destroy Claudin 18.2 expressing gastric tumor cells.

Learn More

Robotic & Keyhole Gastrectomy

Minimally invasive keyhole surgery that removes the tumor with complete lymph node clearance while preserving healthy digestive passages.

Learn More

Heated Chemotherapy (HIPEC)

Circulating heated chemotherapy inside the abdomen during surgery to eliminate microscopic tumor cells and prevent peritoneal recurrence.

Learn More

WHY CHOOSE US

Why Choose China for Stomach Cancer

A specialized clinical pathway connecting international patients with China's top gastric oncology institutes.

China accounts for a significant portion of global gastric cancer treatments, driving world-leading research and clinical trials. Chinese medical institutions achieved the world’s first regulatory approvals for Claudin 18.2 directed therapies and have pioneered effective neoadjuvant conversion protocols that make previously inoperable gastric tumors surgically removable.

Before traveling, your endoscopy records, CT scans, and biomarker testing (Claudin 18.2, HER2, PD-L1) are reviewed by senior gastric oncologists. Treatment is delivered in certified tertiary university hospitals with full bilingual bedside assistance and itemized public billing.

HOW IT WORKS

4 Steps to Treatment in China

A simple, step-by-step process from initial record review to your arrival and treatment in China.

01. Submit Records Online

Upload existing pathology reports, biomarker NGS profiles, and imaging scans through our secure clinical intake portal.

02. Pre-Screen & Doctor Match

Clinical eligibility and contraindication screening, matching your specific case with China's foremost oncology chiefs.

03. Doctor Consultation

One-on-one remote video consultation or written multidisciplinary assessment to confirm treatment protocol before travel.

04. Travel to China & Care

Expedited medical visa support, priority hospital admission, dedicated bilingual bedside escorts, and continuum follow-up.

PATIENT FAQS

Frequently Asked Questions

Key clinical, financial, and logistical insights for international patients considering care in China.

01. What is Claudin 18.2 and how does it help stomach cancer patients?

Claudin 18.2 is a protein present in up to 70% of gastric cancer cells. China’s approved CAR-T and targeted antibody therapies zero in on this protein, offering remarkable tumor shrinkage in advanced cases.

02. Can large or locally advanced stomach tumors be operated on?

Yes. Modern conversion therapy combining targeted pills, immunotherapy, and chemotherapy often shrinks the tumor dramatically, allowing curative surgical resection.

03. What is HIPEC and when is it recommended?

Hyperthermic Intraperitoneal Chemotherapy delivers heated cancer drugs directly into the abdominal cavity during surgery, effectively treating or preventing peritoneal metastasis.

04. How is nutrition supported after stomach surgery?

Dedicated clinical dietitians and nurses provide customized post-operative dietary guidance and enzyme replacement plans to ensure smooth recovery and weight maintenance.

CONFIDENTIAL CASE EVALUATION

Start with a Confidential Clinical Case Review

Submit your basic case details below for an initial eligibility review. Our medical team coordinates directly with chief oncologists at top Chinese cancer centers, returning a preliminary assessment and roadmap within 24–48 hours.

✓ Free initial triage • ✓ Direct specialist coordination • ✓ 100% Confidential